|
1
|
Albright F, Butler A and Bloomberg E:
Rickets resistant to vitamin D therapy. Am J Dis Child. 54:529–547.
1937.
|
|
2
|
Beck-Nielsen SS, Brock-Jacobsen B, Gram J,
Brixen K and Jensen TK: Incidence and prevalence of nutritional and
hereditary rickets in southern Denmark. Eur J Endocrinol.
160:491–497. 2009. View Article : Google Scholar
|
|
3
|
Carpenter TO: New perspectives on the
biology and treatment of X-linked hypophosphatemic rickets. Pediatr
Clin North Am. 44:443–466. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Francis F, Hennig S, Korn B, Reinhardt R,
De Jong P, Poustka A, Lehrach H, Rowe PSN, Goulding JN, Summerfield
T, et al: The HYP Consortium: A gene (PEX) with homologies to
endopeptidases is mutated in patients with X-linked
hypophosphatemic rickets. Nat Genet. 11:130–136. 1995. View Article : Google Scholar
|
|
5
|
White KE, Evans WE, O'Riordan JLH, Speer
MC, Econs MJ, Lorenz-Depiereux B, Grabowski M, Meitinger T and
Strom TM: ADHR Consortium: Autosomal dominant hypophosphataemic
rickets is associated with mutations in FGF23. Nat Genet.
26:345–348. 2000. View
Article : Google Scholar
|
|
6
|
Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan
B, Yu X, Rauch F, Davis SI, Zhang S, et al: Loss of DMP1 causes
rickets and osteomalacia and identifies a role for osteocytes in
mineral metabolism. Nat Genet. 38:1310–1315. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li H, Xie H, Liu W, Hu R, Huang B, Tan YF,
Xu K, Sheng ZF, Zhou HD, Wu XP and Luo XH: A novel microRNA
targeting HDAC5 regulates osteoblast differentiation in mice and
contributes to primary osteoporosis in humans. J Clin Invest.
119:3666–3677. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu R, Liu W, Li H, Yang L, Chen C, Xia ZY,
Guo LJ, Xie H, Zhou HD, Wu XP and Luo XH: A Runx2/miR-3960/miR-2861
regulatory feedback loop during mouse osteoblast differentiation. J
Biol Chem. 286:12328–12339. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li CJ, Cheng P, Liang MK, Chen YS, Lu Q,
Wang JY, Xia ZY, Zhou HD, Cao X, Xie H, et al: MicroRNA-188
regulates age-related switch between osteoblast and adipocyte
differentiation. J Clin Invest. 125:1509–1522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du L, Desbarats M, Viel J, Glorieux FH,
Cawthorn C and Ecarot B: cDNA cloning of the murine Pex gene
implicated in X-linked hypophosphatemia and evidence for expression
in bone. Genomics. 36:22–28. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Francis F, Strom TM, Hennig S, Böddrich A,
Lorenz B, Brandau O, Mohnike KL, Cagnoli M, Steffens C, Klages S,
et al: Genomic organization of the human PEX gene mutated in
X-linked dominant hypophosphatemic rickets. Genome Res. 7:573–585.
1997.PubMed/NCBI
|
|
12
|
Ruchon AF, Tenenhouse HS, Marcinkiewicz M,
Siegfried G, Aubin JE, DesGroseillers L, Crine P and Boileau G:
Developmental expression and tissue distribution of Phex protein:
Effect of the Hyp mutation and relationship to bone markers. J Bone
Miner Res. 15:1440–1450. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nesbitt T, Fujiwara I, Thomas R, Xiao ZS,
Quarles LD and Drezner MK: Coordinated maturational regulation of
PHEX and renal phosphate transport inhibitory activity: Evidence
for the pathophysiological role of PHEX in X-linked
hypophosphatemia. J Bone Miner Res. 14:2027–2035. 1999. View Article : Google Scholar
|
|
14
|
Liu S, Zhou J, Tang W, Jiang X, Rowe DW
and Quarles LD: Pathogenic role of Fgf23 in Hyp mice. Am J Physiol
Endocrinol Metab. 291:E38–E49. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jap TS, Chiu CY, Niu DM and Levine MA:
Three novel mutations in the PHEX gene in Chinese subjects with
hypophosphatemic rickets extends genotypic variability. Calcif
Tissue Int. 88:370–377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia W, Meng X, Jiang Y, Li M, Xing X, Pang
L, Wang O, Pei Y, Yu LY, Sun Y, et al: Three novel mutations of the
PHEX gene in three Chinese families with X-linked dominant
hypophosphatemic rickets. Calcif Tissue Int. 81:415–420. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang QL, Xu J, Zhang Z, He JW, Lu LS, Fu
WZ and Zhang ZL: Three novel PHEX gene mutations in four Chinese
families with X-linked dominant hypophosphatemic rickets. Biochem
Biophys Res Commun. 423:793–798. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yue H, Yu JB, He JW, Zhang Z, Fu WZ, Zhang
H, Wang C, Hu WW, Gu JM, Hu YQ, et al: Identification of two novel
mutations in the PHEX gene in Chinese patients with
hypophosphatemic rickets/osteomalacia. PLoS One. 9:e978302014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu S, Wei M, Xiao J, Wang CY and Qiu ZQ:
Three PHEX gene mutations in Chinese subjects with hypophosphatemic
rickets and literature review. Zhongguo Dang Dai Er Ke Za Zhi.
16:518–523. 2014.In Chinese. PubMed/NCBI
|
|
20
|
Yang L, Yang J and Huang X: PHEX gene
mutation in a Chinese family with six cases of X-linked
hypophosphatemic rickets. J Pediatr Endocrinol Metab. 26:1179–1183.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuan L, Wu S, Xu H, Xiao J, Yang Z, Xia H,
Liu A, Hu P, Lu A, Chen Y, et al: Identification of a novel PHEX
mutation in a Chinese family with X-linked hypophosphatemic rickets
using exome sequencing. Biol Chem. 396:27–33. 2015. View Article : Google Scholar
|
|
22
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ng PC and Henikoff S: SIFT: Predicting
amino acid changes that affect protein function. Nucleic Acids Res.
31:3812–3814. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Smith ER, McMahon LP and Holt SG:
Method-specific differences in plasma fibroblast growth factor 23
measurement using four commercial ELISAs. Clin Chem Lab Med.
51:1971–1981. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sabbagh Y, Boileau G, Campos M, Carmona AK
and Tenenhouse HS: Structure and function of disease-causing
missense mutations in the PHEX gene. J Clin Endocrinol Metab.
88:2213–2222. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Beck-Nielsen SS, Brixen K, Gram J and
Brusgaard K: Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and
CLCN5 in patients with hypophosphatemic rickets. J Hum Genet.
57:453–458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rowe PS, Oudet CL, Francis F, Sinding C,
Pannetier S, Econs MJ, Strom TM, Meitinger T, Garabedian M, David
A, et al: Distribution of mutations in the PEX gene in families
with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet.
6:539–549. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gaucher C, Walrant-Debray O, Nguyen TM,
Esterle L, Garabédian M and Jehan F: PHEX analysis in 118 pedigrees
reveals new genetic clues in hypophosphatemic rickets. Hum Genet.
125:401–411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Filisetti D, Ostermann G, von Bredow M,
Strom T, Filler G, Ehrich J, Pannetier S, Garnier JM, Rowe P,
Francis F, et al: Non-random distribution of mutations in the PHEX
gene, and under-detected missense mutations at non-conserved
residues. Eur J Hum Genet. 7:615–619. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiu ZQ, Tenenhouse HS and Scriver CR:
Parental origin of mutant allele does not explain absence of gene
dose in X-linked Hyp mice. Genet Res. 62:39–43. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Holm IA, Nelson AE, Robinson BG, Mason RS,
Marsh DJ, Cowell CT and Carpenter TO: Mutational analysis and
genotype-phenotype correlation of the PHEX gene in X-linked
hypophosphatemic rickets. J Clin Endocrinol Metab. 86:3889–3899.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jonsson KB, Zahradnik R, Larsson T, White
KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H,
Ljunggren O, et al: Fibroblast growth factor 23 in oncogenic
osteomalacia and X-linked hypophosphatemia. N Engl J Med.
348:1656–1663. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Weber TJ, Liu S, Indridason OS and Quarles
LD: Serum FGF23 levels in normal and disordered phosphorus
homeostasis. J Bone Miner Res. 18:1227–1234. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aono Y, Yamazaki Y, Yasutake J, Kawata T,
Hasegawa H, Urakawa I, Fujita T, Wada M, Yamashita T, Fukumoto S
and Shimada T: Therapeutic effects of anti-FGF23 antibodies in
hypophosphatemic rickets/osteomalacia. J Bone Miner Res.
24:1879–1888. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sapir-Koren R and Livshits G: Bone
mineralization is regulated by signaling cross talk between
molecular factors of local and systemic origin: The role of
fibroblast growth factor 23. Biofactors. 40:555–568. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sitara D, Kim S, Razzaque MS, Bergwitz C,
Taguchi T, Schüler C, Erben RG and Lanske B: Genetic evidence of
serum phosphate-independent functions of FGF-23 on bone. PLoS
Genet. 4:e10001542008. View Article : Google Scholar : PubMed/NCBI
|
